Ethic Inc. Purchases 36,651 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

Ethic Inc. grew its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 258.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 50,856 shares of the company's stock after purchasing an additional 36,651 shares during the period. Ethic Inc. owned approximately 0.10% of Nu Skin Enterprises worth $350,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of NUS. Deutsche Bank AG raised its stake in Nu Skin Enterprises by 53.9% during the fourth quarter. Deutsche Bank AG now owns 50,262 shares of the company's stock valued at $346,000 after buying an additional 17,605 shares during the last quarter. D. E. Shaw & Co. Inc. boosted its stake in Nu Skin Enterprises by 15.5% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock worth $15,512,000 after purchasing an additional 301,295 shares in the last quarter. Balyasny Asset Management L.P. boosted its stake in Nu Skin Enterprises by 5.2% in the 4th quarter. Balyasny Asset Management L.P. now owns 105,578 shares of the company's stock worth $727,000 after purchasing an additional 5,209 shares in the last quarter. BNP Paribas Financial Markets grew its position in Nu Skin Enterprises by 61.4% during the 4th quarter. BNP Paribas Financial Markets now owns 231,260 shares of the company's stock valued at $1,593,000 after purchasing an additional 87,941 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in Nu Skin Enterprises by 115.1% during the 4th quarter. Ameriprise Financial Inc. now owns 238,237 shares of the company's stock valued at $1,641,000 after purchasing an additional 127,474 shares in the last quarter. Hedge funds and other institutional investors own 82.84% of the company's stock.

Nu Skin Enterprises Stock Performance

Shares of Nu Skin Enterprises stock traded up $0.14 during trading on Tuesday, hitting $7.59. 340,452 shares of the company's stock traded hands, compared to its average volume of 833,262. The business has a 50-day simple moving average of $6.66 and a 200-day simple moving average of $7.00. Nu Skin Enterprises, Inc. has a 1 year low of $5.32 and a 1 year high of $13.90. The stock has a market capitalization of $375.04 million, a P/E ratio of -2.57 and a beta of 0.92. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.08. The company had revenue of $364.49 million for the quarter, compared to analysts' expectations of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. As a group, analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 11th. Stockholders of record on Friday, May 30th will be given a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 3.16%. The ex-dividend date of this dividend is Friday, May 30th. Nu Skin Enterprises's payout ratio is currently -30.00%.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Monday, May 12th.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.